1 / 4

Precision Medicine Market: Global Industry Growth, Market Size, Share and Forecast 2019-2025

The global precision medicine market is estimated to grow at a CAGR of 9.8% during the forecast period. Identification of biomarkers is very essential to develop and realize the potential of precision medicine. Researches conducted by the different research institutes have turned to the proteomics, for developing new biomarkers.

supershiba
Download Presentation

Precision Medicine Market: Global Industry Growth, Market Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Precision Medicine Market: Global Market Size, Industry Trends, Leading Players, Market Share and Forecast 2019-2025 For free sample request visit: https://www.omrglobal.com/request- sample/precision-medicine-market Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. Precision Medicine Market: Global Market Size, Industry Trends, Leading Players, Market Share and Forecast 2019-2025 The global precision medicine market is estimated to grow at a CAGR of 9.8% during the forecast period.Identification of biomarkers is very essential to develop and realize the potential of precision medicine. Researches conducted by the different research institutes have turned to the proteomics, for developing new biomarkers. These latest researches have improved the accuracy of the biomarkers as early diagnosis of the diseases help the physicians to provide better treatment. Presently, scientists are focusing on the gene expression for detecting the results of the therapy process. In June 2018, the National Cancer Institute (NCI) has sponsored a Trial Assigning Individualized Option for treatment (Rx), or TAILORx. This test enabled the scientists and other healthcare providers to assign patients to the most appropriate and effective treatment. Thereby, unfolding growth opportunities for the global precision medicine market. The biomarkers test is being utilized to find the risk factor of the reoccurrence of breast cancer. In 2015, there was an investment made by the Precision Medical Initiative of around $70 million to the National Cancer Institute. The investment was made to recognize the different genomic drivers in cancer and to develop new approaches for the diagnosis of cancer. Browse the full report description of Global Precision Medicine Market athttps://www.omrglobal.com/industry- reports/precision-medicine-market In October 2017, the US-based company called Gentris, working in the field of genomic biomarkers in clinical studies, signed a Memorandum of Understanding to form abiomarker collaboration with the Shanghai Institutes of Preventative Medicine. This partnership was aimed to discover new biomarkers. It may result in the development of the effective precision medicine. Thus, likely to expand the market size for global precision medicine market. Moreover, in April 2017, Oxford Cancer Biomarkers with the collaboration of My-BioMed Biotechnology (MBM) expanded the use of three of its in-vitro diagnostic tests for colorectal cancer into China. Increasing personalized treatment has focused on pharmaceutical companies for investments in biomarkers. These three tests have been developed for colorectal cancer by OCB (Oxford Cancer Biomarker) and are intended for distributing personalized medicine and are part of a portfolio. This strategic collaboration will permit patients across China to access OCB’s suite of precision oncology diagnostic technologies and specific needs of the Chinese market. This enables in building a robust product pipeline of diagnostics exactly aimed at the population of China.

  3. Current Market Trends Covered in the Global Precision Medicine Market Report  On the basis of the application segment, the oncology application segment is estimated to hold the maximum market share over the forecast period. Asia-Pacific is estimated to gain maximum traction in the global precision medicine industry during the forecast period.  Global Precision Medicine Market Segmentation By Technology    Genomics Transcriptomics Epigenomics By Application     Oncology Neurology Immunology Others (Respiratory) By End-Use    Pharmaceutical Companies Diagnostic Companies Healthcare IT Companies Global Precision Medicine Market – Segment by Region North America   US Canada Europe    Germany UK France

  4.   Spain Italy Rest of Europe Asia-Pacific     China Japan India Rest of Asia-Pacific Rest of the World   Latin America Middle East and Africa To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/precision-medicine-market Related Report: Hyaluronic Acid-based Dermal Fillers Market About Us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-040

More Related